Skip to search formSkip to main contentSkip to account menu

KRP-109

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzoxazinesPyrrolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation.
2012
2012
In vivo efficacy of KRP-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumonia
2010
2010
KRP-109, A Novel Neutrophil Elastase Inhibitor Decreases Expression Of TGF-² Signal Related Genes In Bleomycin-induced Lung Injury Model
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)